Holtzman Douglas's Form 4 filing
Icosavax, Inc. (ICVX) · filed Aug 2, 2022
- Accession no.
- 0001209191-22-044021
- Filed
- Aug 2, 2022
- Trade date
- Feb 18-Aug 2, 2022
- Filing delay
- 165 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $69.2K. It was filed 165 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Holtzman DouglasCIK 0001874371 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock | SSaleDisposed | −585 | $7.11 | −$4,159.35 | 303,048 | Direct | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −9,337 | $6.64 | −$61,997.68 | 293,711 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −453 | $6.70 | −$3,035.1 | 293,258 | Direct | |
| Feb 18, 2022 | Common Stock | GGiftDisposed | −20,000 | $0.00 | $0 | 22,440 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.